Internal Audit Effectiveness on Corporate Governance and Financial Fraudulent Risk: Evidence from Kangmei Pharmaceutical

Yunjiao Wu

2025

Abstract

Over the last decade, financial fraud has occurred more frequently as it has become increasingly complicated, organized, and systematic, given the rapid growth of small and medium-sized enterprises. Due to the sudden economic downturn post-pandemic, firms facing extensive financial pressure tend to act more aggressively, eventually leading to the incentive to commit fraud. Thus, the research on financial fraud and its relationship with firms’ corporate mechanisms is of great significance in helping the public better conduct control samples for future fraud prevention. Applying Kangmei Pharmaceutical’s financial fraud case as a recent example, given the current accounting system and theoretical framework of fraud, by analyzing its internal audit quality and corporate governance, this article provides insight into how internal audit quality and corporate governance will ultimately contribute to the overall fraud risk.

Paper Citation

in Harvard Style

Wu Y. (2025). Internal Audit Effectiveness on Corporate Governance and Financial Fraudulent Risk: Evidence from Kangmei Pharmaceutical. In Proceedings of the 2nd International Conference on Public Relations and Media Communication - Volume 1: PRMC; ISBN 978-989-758-778-8, SciTePress, pages 144-150. DOI: 10.5220/0013987500004916

in Bibtex Style

@conference{prmc25,
author={Yunjiao Wu},
title={Internal Audit Effectiveness on Corporate Governance and Financial Fraudulent Risk: Evidence from Kangmei Pharmaceutical},
booktitle={Proceedings of the 2nd International Conference on Public Relations and Media Communication - Volume 1: PRMC},
year={2025},
pages={144-150},
publisher={SciTePress},
organization={INSTICC},
doi={10.5220/0013987500004916},
isbn={978-989-758-778-8},
}

in EndNote Style

TY - CONF

JO - Proceedings of the 2nd International Conference on Public Relations and Media Communication - Volume 1: PRMC
TI - Internal Audit Effectiveness on Corporate Governance and Financial Fraudulent Risk: Evidence from Kangmei Pharmaceutical
SN - 978-989-758-778-8
AU - Wu Y.
PY - 2025
SP - 144
EP - 150
DO - 10.5220/0013987500004916
PB - SciTePress